Azienda Ospedaliera Universitaria Senese

Institution (Healthcare)

Homepage ROR

Also Known As

Azienda Ospedaliera Universitaria Senese

3.4K

Publications

223.4K

Citations

229

Authors

782

Concepts

About

Azienda Ospedaliera Universitaria Senese is a healthcare institution in Siena, Italy known for medicine, pathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	35	202	8.2K
2	Engineering	15	51	1.1K
3	Arts	5	17	469
4	Education	2	7	490
5	Language Studies	1	5	125

Azienda Ospedaliera Universitaria Senese

3.4K

Publications

223.4K

Citations

Page 1

	Year	Citations
Diagnostic criteria for Menière's disease José A. López‐Escámez, John P. Carey, Won-Ho Chung, Journal of Vestibular Research DiagnosisOtorhinolaryngologyNeurotologyPeripheral Vestibular SystemSocial Sciences	2015	1.4K
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Nature Medicine UrologyGenitourinary CancerMedicinePathologyBevacizumab Versus Sunitinib	2018	1.2K
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial Paolo A. Ascierto, Grant A. McArthur, Brigitte Dréno, The Lancet Oncology MedicineAdvanced Brafv600-mutant MelanomaMelanomaImmune Checkpoint InhibitorDermatology	2016	986
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients Ricard Cervera, Rosa Serrano, Guillermo Pons‐Estel, Annals of the Rheumatic Diseases	2014	941
Inhaler mishandling remains common in real life and is associated with reduced disease control Andrea S. Melani, Marco Bonavia, Vincenzo Cilenti, Respiratory Medicine AsthmaAllergyInflammatory Lung DiseaseRespiratory ToxicologyRespiratory Diseases	2011	921
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma Antoni Ribas, Richard Kefford, Margaret Marshall, Journal of Clinical Oncology	2013	811
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi, The Lancet Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationOncology	2015	726
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, The Lancet Haematology	2016	582
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, The Lancet Haematology	2020	551
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma Maria Colombino, Mariaelena Capone, Amelia Lissia, Journal of Clinical Oncology	2012	453

Page 1